Search Results - Gujral, Taran

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Abstract A115: A novel therapy targeting Wnt receptor in metastatic solid tumors

    Abstract A115: A novel therapy targeting Wnt receptor in metastatic solid tumors by Gujral, Taran, Kirschner, Marc

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract B32: High-throughput chemical screening reveals YAP-mediated alterations in drug sensitivities

    Abstract B32: High-throughput chemical screening reveals YAP-mediated alterations in drug sensitivities by Bondesson, Andrew J., Miyaki, Aya, Shin, Stella, Ceribelli, Michele, Thomas, Craig J., Gujral, Taran S.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Correlative Analysis

    Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Corre... by Poh, Christina, Chow, Victor A, Lynch, Ryan C, Ujjani, Chaitra S, Shadman, Mazyar, Till, Brian G, Raghunathan, Vikram, Warren, Edus H, Gauthier, Jordan, Smith, Stephen D, Gujral, Taran, Morishima, Chihiro, Wu, Qian, Voutsinas, Jenna M, Sperling, Amy, Dizon, Joshua, Maloney, David G, Gopal, Ajay K

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation

    Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation by Olson, Annabel T, Kang, Yuqi, Ladha, Anushka M, Chuan Bian Lim, Lagunoff, Michael, Gujral, Taran S, Geballe, Adam P

    Published in bioRxiv
    Request full text
    Article
    Save to List
    Saved in:
  5. 5
    Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Correlative Analysis

    Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Corre... by Poh, Christina, Chow, Victor A, Lynch, Ryan C, Ujjani, Chaitra S, Warren, Edus H, Shadman, Mazyar, Till, Brian G, Raghunathan, Vikram, Gauthier, Jordan, Hirayama, Alexandre V, Smith, Stephen D, Gujral, Taran, Morishima, Chihiro, Wu, Vicky, Voutsinas, Jenna M, Dizon, Joshua, Maloney, David G., Gopal, Ajay K

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release

    Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release by Chan, Marina, Holland, Eric, Gujral, Taran

    Published in bioRxiv
    Request full text
    Article
    Save to List
    Saved in:

Search Tools: